Validation of the Arabic Version of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale

被引:7
|
作者
Khalil, Hanan [1 ,2 ]
Aldaajani, Zakiyah F. [3 ]
Aldughmi, Mayis [4 ]
Al-Sharman, Alham [2 ]
Mohammad, Tareq [5 ]
Mehanna, Raja [6 ]
El-Jaafary, Shaimaa, I [7 ]
Dahshan, Ahmed [7 ]
Ben Djebara, Mouna [8 ]
Kamel, Walaa A. [9 ,10 ]
Amer, Hanan A. [11 ]
Farghal, Mohammed [12 ]
Abdulla, Fatema [13 ]
Al-Talai, Nouf [14 ]
Abu Snineh, Muneer [15 ]
Farhat, Nouha [16 ]
Jamali, Fatima A. [17 ]
Matar, Rawan K. [12 ]
Abdelraheem, Heba S. [18 ]
Ghonimi, Nesma A. M. [19 ]
Abu Al-Melh, Mishal [12 ]
Elbhrawy, Sonia [18 ]
Alotaibi, Majid S. [19 ]
Elaidy, Shaimaa A. [19 ]
Almuammar, Shahad A. [19 ]
Al-Hashel, Jasem Y. [20 ]
Gouider, Riadh [21 ]
Samir, Hatem [11 ]
Mhiri, Chokri [17 ]
Skorvanek, Matej [22 ,23 ]
Lin, Jeffrey [24 ]
Martinez-Martin, Pablo [25 ]
Stebbins, Glenn T. [26 ]
Luo, Sheng [27 ]
Goetz, Christopher G. [26 ]
Bajwa, Jawad A. [28 ]
机构
[1] Qatar Univ, Coll Hlth Sci, Dept Phys Therapy & Rehabil Sci, QU Hlth, Doha, Qatar
[2] Jordan Univ Sci & Technol, Fac Appl Med Sci, Dept Rehabil Sci, Irbid, Jordan
[3] King Fahad Med Mil Complex, Neurol Unit, Dhahran, Saudi Arabia
[4] Univ Jordan, Sch Rehabil Sci, Dept Physiotherapy, Amman, Jordan
[5] Execut Adm Nursing Affairs, Natl Neurosci Nursing Adm, Riyadh, Saudi Arabia
[6] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Houston, TX 77030 USA
[7] Cairo Univ, Kasr Al Ainy Sch Med, Neurol Dept, Cairo, Egypt
[8] Univ Tunis El Manar, Clin Invest Ctr, Fac Med Tunis, Dept Neurol,Razi Univ Hosp, Tunis, Tunisia
[9] Beni Suef Univ, Neurol Dept, Bani Suwayf, Egypt
[10] Ibn Sina Hosp, Neurol Dept, Kuwait, Kuwait
[11] Cairo Univ, Kasr Al Ainy Sch Med, Cairo, Egypt
[12] Al Adan Hosp, Neurol Div, Kuwait, Kuwait
[13] Salmaniya Med Complex, Clin Neurosci Dept, Manama, Bahrain
[14] Rashid Hosp, Neurol Dept, Dubai, U Arab Emirates
[15] Hadassah Hebrew Univ Hosp, Neurol Dept, Jerusalem, Israel
[16] Habib Bourguiba Hosp Univ Ctr, Clin Invest Ctr, Dept Neurol, Sfax, Tunisia
[17] Univ Jordan, Cell Therapy Ctr, Amman, Jordan
[18] Alexandria Univ, Fac Med, Dept Neurol, Alexandria, Egypt
[19] Zagazig Univ, Dept Neurol, Zagazig, Egypt
[20] King Fahd Specialist Hosp, Neurosci Ctr, Dammam, Saudi Arabia
[21] Tunis El Manar Univ, Clin Invest Ctr, Fac Med Tunis, Dept Neurol,Razi Hosp, Tunis, Tunisia
[22] Safarik Univ, Dept Neurol, Kosice, Slovakia
[23] Univ Hosp L Pasteur, Dept Neurol, Kosice, Slovakia
[24] Univ Texas Hlth Sci Ctr Houston, Dept Biostat & Data Sci, Houston, TX 77030 USA
[25] Carlos III Inst Hlth, Ctr Networked Biomed Res Neurodegenerat Dis CIBER, Madrid, Spain
[26] Rush Univ, Dept Neurol Sci, Med Ctr, Chicago, IL 60612 USA
[27] Duke Univ, Dept Biostat & Bioinformat, Durham, NC USA
[28] King Fahad Med City, Dept Neurol, Natl Neurosci Inst, Riyadh, Saudi Arabia
基金
美国国家卫生研究院;
关键词
validation; rating scale; Parkinson's disease;
D O I
10.1002/mds.28905
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background The Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) has become the gold standard for evaluating different domains in Parkinson's disease (PD), and it is commonly used in clinical practice, research, and clinical trials. Objectives The objectives are to validate the Arabic-translated version of the MDS-UPDRS and to assess its factor structure compared with the English version. Methods The study was carried out in three phases: first, the English version of the MDS-UPDRS was translated into Arabic and subsequently back-translated into English by independent translation team; second, cognitive pretesting of selected items was performed; third, the Arabic version was tested in over 400 native Arabic-speaking PD patients. The psychometric properties of the translated version were analyzed using confirmatory factor analysis (CFA) as well as exploratory factor analysis (EFA). Results The factor structure of the Arabic version was consistent with that of the English version based on the high CFIs for all four parts of the MDS-UPDRS in the CFA (CFI >= 0.90), confirming its suitability for use in Arabic. Conclusions The Arabic version of the MDS-UPDRS has good construct validity in Arabic-speaking patients with PD and has been thereby designated as an official MDS-UPDRS version. The data collection methodology among Arabic-speaking countries across two continents of Asia and Africa provides a roadmap for validating additional MDS rating scale initiatives and is strong evidence that underserved regions can be energically mobilized to promote efforts that apply to better clinical care, education, and research for PD. (c) 2022 International Parkinson and Movement Disorder Society
引用
收藏
页码:826 / 841
页数:16
相关论文
共 50 条
  • [21] Utility of movement disorder society-unified Parkinson's disease rating scale for evaluating effect of subthalamic nucleus deep brain stimulation
    Yamamoto, Tatsuya
    Yamanaka, Yoshitaka
    Hirano, Shigeki
    Higuchi, Yoshinori
    Kuwabara, Satoshi
    FRONTIERS IN NEUROLOGY, 2023, 13
  • [22] Relationship of Movement Disorders Society-Unified Parkinson's Disease Rating Scale Nonmotor Symptoms to Cognitive Functioning in Patients with Parkinson's Disease
    Bernard, Bryan A.
    Carns, Danielle
    Stebbins, Glenn T.
    Goldman, Jennifer G.
    Goetz, Christopher G.
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2020, 7 (03): : 279 - 283
  • [23] Longitudinal Change and Progression Indicators Using the Movement Disorder Society-Unified Parkinson's Disease Rating Scale in Two Independent Cohorts with Early Parkinson's Disease
    Bartl, Michael
    Dakna, Mohammed
    Schade, Sebastian
    Wicke, Tamara
    Lang, Elisabeth
    Ebentheuer, Jens
    Weber, Sandrina
    Trenkwalder, Claudia
    Mollenhauer, Brit
    JOURNAL OF PARKINSONS DISEASE, 2022, 12 (01) : 437 - 452
  • [24] Treatment Detection and Movement Disorder Society-Unified Parkinson's Disease Rating Scale, Part III Estimation Using Finger Tapping Tasks
    ZhuParris, Ahnjili
    Thijssen, Eva
    Elzinga, Willem O. O.
    Makai-Boloni, Soma
    Kraaij, Wessel
    Groeneveld, Geert J. J.
    Doll, Robert J. J.
    MOVEMENT DISORDERS, 2023, 38 (10) : 1795 - 1805
  • [25] Expanded and independent validation of the Movement Disorder Society–Unified Parkinson’s Disease Rating Scale (MDS-UPDRS)
    Pablo Martinez-Martin
    Carmen Rodriguez-Blazquez
    Mario Alvarez-Sanchez
    Tomoko Arakaki
    Alberto Bergareche-Yarza
    Anabel Chade
    Nelida Garretto
    Oscar Gershanik
    Monica M. Kurtis
    Juan Carlos Martinez-Castrillo
    Amelia Mendoza-Rodriguez
    Henry P. Moore
    Mayela Rodriguez-Violante
    Carlos Singer
    Barbara C. Tilley
    Jing Huang
    Glenn T. Stebbins
    Christopher G. Goetz
    Journal of Neurology, 2013, 260 : 228 - 236
  • [26] Inconsistent Movement Disorders Society-Unified Parkinson's Disease Rating Scale Part III Ratings in the Parkinson's Progression Marker Initiative
    Turner, Travis H.
    Dale, Marian L.
    MOVEMENT DISORDERS, 2020, 35 (08) : 1488 - 1489
  • [27] Novel Approach to Movement Disorder Society-Unified Parkinson's Disease Rating Scale Monitoring in Clinical Trials: Longitudinal Item Response Theory Models
    Luo, Sheng
    Zou, Haotian
    Goetz, Christopher G.
    Choi, Dongrak
    Oakes, David
    Simuni, Tanya
    Stebbins, Glenn T.
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2021, 8 (07): : 1083 - 1091
  • [28] Turkish Standardization of Movement Disorders Society Unified Parkinson's Disease Rating Scale and Unified Dyskinesia Rating Scale
    Akbostanci, Muhittin C.
    Bayram, Ece
    Yilmaz, Volkan
    Rzayev, Sefer
    Ozkan, Serhat
    Tokcaer, Ayse Bora
    Saka, Esen
    Celik, Fatma N. Durmaz
    Barut, Banu Ozen
    Tufekcioglu, Zeynep
    Acarer, Ahmet
    Balaban, Hatice
    Erer, Sevda
    Dogu, Okan
    Kibaroglu, Seda
    Aydin, Nursel
    Hanagasi, Hasmet
    Elibol, Bulent
    Emre, Murat
    Stebbins, Glenn T.
    Goetz, Christopher G.
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2018, 5 (01): : 54 - 59
  • [29] Validation of the Portuguese version of the Movement Disorder Society non-motor rating scale (MDS-NMS) in Parkinson's disease
    Vale, Thiago Cardoso
    Santos, Daniela Pereira
    de Oliveira, Daniel Sabino
    Brandao, Pedro Renato de Paula
    Pereira, Danilo Assis
    Bouca-Machado, Raquel
    Silva, Leonardo Oliveira
    Rieder, Carlos Roberto de Mello
    Barbosa, Egberto Reis
    Cury, Rubens Gisbert
    Parmera, Jacy Bezerra
    Teive, Helio Afonso Ghizoni
    Ferreira, Matheus Gomes
    Ferraz, Henrique Ballalai
    da Silva, Carolina Candeias
    Tumas, Vitor
    Cunha, Ana Luiza Nunes
    Braga-Neto, Pedro
    Lima, Danielle Pessoa
    Della Colleta, Marcus Vinicius
    Maia, Debora
    Fontana, Marco de Souza
    Damas, Catarina N.
    Lobo, Patricia Pita
    Rebordao, Leonor
    Magalhaes, Andreia D.
    Peralta, Ana Rita
    Simoes, Rita M.
    Lampreia, Tania
    Velon, Ana Graca
    Carneiro, Diogo
    Raimundo, Rita
    Gago, Miguel
    Mendes, Alexandre
    Cha, Nuno Vila
    Damasio, Joana
    Costa, Sara
    Lopes, Rui
    Morgadinho, Ana
    Mestre, Tiago
    Stebbins, Glenn T.
    Luo, Sheng
    Goetz, Christopher G.
    Ferreira, Joaquim J.
    Cardoso, Francisco
    PARKINSONISM & RELATED DISORDERS, 2025, 132
  • [30] How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson's disease rating scale: Comparison with the unified Parkinson's disease rating scale
    Stebbins, Glenn T.
    Goetz, Christopher G.
    Burn, David J.
    Jankovic, Joseph
    Khoo, Tien K.
    Tilley, Barbara C.
    MOVEMENT DISORDERS, 2013, 28 (05) : 668 - 670